Optical measurement of isolated canine lung filtration coefficients after alloxan infusion.
In this study, lung filtration coefficient (Kfc) was measured in eight isolated canine lung preparations by using three methods: standard gravimetric (Std), blood-corrected gravimetric (BC), and optical. The lungs were held in zone III conditions and were subjected to an average venous pressure increase of 8.79 +/- 0.93 (mean +/- SD) cmH2O. The permeability of the lungs was increased with an infusion of alloxan (75 mg/kg). The resulting Kfc values (in milliliters . min-1 . cmH2O-1 . 100 g dry lung weight-1) measured by using Std and BC gravimetric techniques before vs. after alloxan infusion were statistically different: Std, 0.527 +/- 0.290 vs. 1. 966 +/- 0.283; BC, 0.313 +/- 0.290 vs. 1.384 +/- 0.290. However, the optical technique did not show any statistical difference between pre- and postinjury with alloxan, 0.280 +/- 0.305 vs. 0.483 +/- 0. 297, respectively. The alloxan injury, quantified by using multiple-indicator techniques, showed an increase in permeability and a corresponding decrease in reflection coefficient for albumin (sigmaf). Because the optical method measures the product of Kfc and sigmaf, this study shows that albumin should not be used as an intravascular optical filtration marker when permeability is elevated. However, the optical technique, along with another means of measuring Kfc (such as BC), can be used to calculate the sigmaf of a tracer (in this study, sigmaf of 0.894 at baseline and 0.348 after injury). Another important finding of this study was that the ratio of baseline-to-injury Kfc values was not statistically different for Std and BC techniques, indicating that the percent contribution of slow blood-volume increases does not change because of injury.
Klaesner
J W
JW
Department of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee 37235, USA.
Pou
N A
NA
Parker
R E
RE
Finney
C
C
Roselli
R J
RJ
D000496:Alloxan / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology; D015824:Blood-Air Barrier / Q000187:drug effects / Q000502:physiology; D004396:Coloring Agents; D004285:Dogs; D005070:Evans Blue; D066298:In Vitro Techniques; D007201:Indicator Dilution Techniques; D008168:Lung / Q000187:drug effects / Q000502:physiology*; D008954:Models, Biological; D010539:Permeability / Q000187:drug effects; D012129:Respiratory Function Tests / Q000295:instrumentation / Q000379:methods*
D004396:Coloring Agents; D005070:Evans Blue; D000496:Alloxan